Intratumoral IL-12 mRNA Shrinks Distant Lesions in PD-1–Resistant Melanoma
STX-001, an intratumoral IL-12 self-replicating mRNA, delivered a 33% ORR in PD-1–resistant melanoma at 100 µg, with abscopal regression and 8.7-month median response duration.